Stephan Hjorth
Affiliations: | Integrative Pharmacology, AstraZeneca R&D, Molndal, Sweden |
Area:
CNS, appetite, serotonin, cannabinoid, in vivoGoogle:
"Stephan Hjorth"Mean distance: 17.32 (cluster 6) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Collaborators
Sign in to add collaborator| Matthew P. Galloway | collaborator | 1989-1996 | Wayne State Univ Sch Med |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hjorth S, Waters S, Waters N, et al. (2020) . The Journal of Pharmacology and Experimental Therapeutics |
| Waters S, Sonesson C, Svensson P, et al. (2020) Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics |
| Jansson-Löfmark R, Hjorth S, Gabrielsson J. (2020) Does in vitro potency predict clinical efficacious concentrations? Clinical Pharmacology and Therapeutics |
| Hjorth S. (2016) Looking back (and in)to the future: A personal reflection on 'Serotonin autoreceptor function and antidepressant drug action' (Hjorth et al., 2000). Journal of Psychopharmacology (Oxford, England) |
| Walsh SK, Hepburn CY, Keown O, et al. (2015) Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach. Pharmacology Research & Perspectives. 3: e00143 |
| Hjorth S, Karlsson C, Jucaite A, et al. (2015) A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates. Neuropharmacology |
| Karlsson C, Hjorth S, Karpefors M, et al. (2015) Baseline anandamide levels and body weight impact the weight loss effect of CB1 receptor antagonism in male rats. Endocrinology. 156: 1237-41 |
| Skowronski AA, Morabito MV, Mueller BR, et al. (2014) Effects of a novel MC4R agonist on maintenance of reduced body weight in diet-induced obese mice. Obesity (Silver Spring, Md.). 22: 1287-95 |
| Wennerberg M, Cheng L, Hjorth S, et al. (2011) Binding properties of antagonists to cannabinoid receptors in intact cells. Fundamental & Clinical Pharmacology. 25: 200-10 |
| Boström J, Olsson RI, Tholander J, et al. (2010) Novel thioamide derivatives as neutral CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20: 479-82 |